Literature DB >> 23093322

Management of ureterovaginal fistulae: an audit.

N Rajamaheswari1, Archana Bharti Chhikara, K Seethalakshmi.   

Abstract

INTRODUCTION AND HYPOTHESIS: A retrospective study was done from January 2008 to January 2011 to analyze the outcome of ureterovaginal fistula management in relation to intervention mode. PATIENTS AND METHODS: Eighteen patients who developed ureterovaginal fistulae following gynecological and obstetric procedures were studied. Ureteroscopic stenting was attempted in 17 cases, and one patient electively underwent ureteral reimplantation.
RESULTS: Ureteroscopic stenting was successfully accomplished in 13 of 17 patients; four patients underwent ureteral reimplantation, as stenting was not feasible. The success rate was 100 % at a mean follow-up of 24.6 months, irrespective of modality.
CONCLUSION: The majority of iatrogenic ureterovaginal fistulae can be successfully managed by ureteroscopic stenting. Our study also suggests that ureteroscopic stenting should be considered as the primary mode of intervention in all cases. Ureteral reimplantation is required and remains practicable when stenting turns out to be impossible.

Entities:  

Mesh:

Year:  2012        PMID: 23093322     DOI: 10.1007/s00192-012-1959-9

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN: 0937-3462            Impact factor:   2.894


  9 in total

1.  Ureteric injuries: diagnosis, management, and outcome.

Authors:  A M Ghali; E M El Malik; A I Ibrahim; G Ismail; M Rashid
Journal:  J Trauma       Date:  1999-01

2.  Ureterovaginal fistula: summary of 18 years' experience.

Authors:  A K Mandal; S K Sharma; S Vaidyanathan; A K Goswami
Journal:  Br J Urol       Date:  1990-05

3.  A combined antegrade and retrograde technique for reestablishing ureteral continuity.

Authors:  M A Beaghler; F C Taylor; K P McLaughlin
Journal:  Tech Urol       Date:  1997

4.  Use of endoscopy in the management of postoperative ureterovaginal fistula.

Authors:  S Elabd; G Ghoniem; M Elsharaby; M Emran; A Elgamasy; T Felfela; A Elshaer
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  1997

5.  Percutaneous management of ureteral injuries that are diagnosed late after cesarean section.

Authors:  Bahri Ustunsoz; Sahin Ugurel; Namik Kemal Duru; Yasar Ozgok; Ayfer Ustunsoz
Journal:  Korean J Radiol       Date:  2008 Jul-Aug       Impact factor: 3.500

6.  Endoscopic management of total ureteral occlusion and ureterovaginal fistula.

Authors:  J E Lingeman; M Y Wong; J R Newmark
Journal:  J Endourol       Date:  1995-10       Impact factor: 2.942

7.  Vesicovaginal and ureterovaginal fistulas: a summary of 25 years of experience.

Authors:  W E Goodwin; P T Scardino
Journal:  J Urol       Date:  1980-03       Impact factor: 7.450

8.  The changing management of ureterovaginal fistulas.

Authors:  A A Selzman; J P Spirnak; E D Kursh
Journal:  J Urol       Date:  1995-03       Impact factor: 7.450

9.  The management of bilateral ureteric injury following radical hysterectomy.

Authors:  Matthew B K Shaw; Mark Tomes; David A Rix; Trevor J Dorkin; Lakkur N S Murthy; Robert S Pickard
Journal:  Adv Urol       Date:  2008
  9 in total
  4 in total

1.  Early urinary diversion facilitates stent placement and conservative management of surgical ureteric injuries.

Authors:  Ranjit Chaudhary; Jyoti Nath Modi; Nidhi Jain; Rakesh Biswas
Journal:  BMJ Case Rep       Date:  2015-02-09

2.  What is your diagnosis?

Authors:  Hasan Terzi; Tayyar Alp Ozkan; Ahmet Kale
Journal:  J Turk Ger Gynecol Assoc       Date:  2012-12-01

3.  Ureterovaginal fistula: a case series.

Authors:  J Shaw; E Tunitsky-Bitton; M D Barber; J E Jelovsek
Journal:  Int Urogynecol J       Date:  2013-12-18       Impact factor: 2.894

4.  Our Experience with Iatrogenic Ureteric Injuries among Women Presenting to University College Hospital, Ibadan: A Call to Action on Trigger Factors.

Authors:  Olatunji Lawal; Oluwasomidoyin Bello; Imran Morhason-Bello; Rukiyat Abdus-Salam; Oladosu Ojengbede
Journal:  Obstet Gynecol Int       Date:  2019-02-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.